GMU scientists design nanoparticle for use in early disease detection

Published



Scientists at George Mason University have developed a new technology to detect diseases such as cancer at an earlier stage than with standard testing methods.

They plan to take their innovation into the commercial market this year, followed by widespread distribution in physicians’ offices.

Full midterm coverage.Deeper analysis.

Get unlimited access to Washington Examiner's reporting, expert analysis, and coverage of the midterm elections.

Get Unlimited Access

Cancel anytime.